CLINICAL TRIALS PROFILE FOR RIZATRIPTAN BENZOATE
✉ Email this page to a colleague
All Clinical Trials for RIZATRIPTAN BENZOATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00516737 ↗ | Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2007-10-03 | The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack. |
| NCT00812006 ↗ | A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 2009-03-24 | This study will provide additional efficacy data for rizatriptan when used for an acute migraine attack in patients already taking topiramate for migraine prophylaxis. |
| NCT00898677 ↗ | Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 1995-09-01 | A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatment of migraine attacks and duration of relief provided. This study will also provide additional efficacy data on rizatriptan 5 mg and 10 mg for the treatment of migraine. |
| NCT00899379 ↗ | Treatment of Multiple Attacks of Acute Migraine (0462-025) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 1995-04-01 | A study to evaluate rizatriptan for the treatment of multiple attacks of acute migraine compared to placebo. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RIZATRIPTAN BENZOATE
Condition Name
Clinical Trial Progress for RIZATRIPTAN BENZOATE
Clinical Trial Phase
Clinical Trial Sponsors for RIZATRIPTAN BENZOATE
Sponsor Name
